In this review, we discuss the biology and physiology of Mstn and Act-A in the vascular wall, focusing on the experimental and clinical data describing the involvement of these TGF-β ligands in the processes of the maintenance of the vascular wall, the calcification processes and CKD-related mineral bone disorder (CKD-MBD). This evidence concerns the gene MSTN and chronic kidney disease.